By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


EXACT Sciences Corporation 

100 Campus Drive

Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-683-1200 Fax: 508-683-1201


Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer.


February 10, 1995


CEO: Kevin Conroy

CMO (Medical): Barry Berger

CFO: John Bakewell

CSO (Scientific): Graham Lidgard


Please click here for Exact Science job opportunitites.



Key Statistics

Ownership: Public

Web Site: EXACT Sciences
Symbol: EXAS

Company News
Apples to Apples: Comparing EXACT Sciences (EXAS) to Myriad Genetics (MYGN) 8/15/2016 8:56:03 AM
EXACT Sciences (EXAS) Release: Cologuard Coverage Expands With Updated Policies From HCSC And Florida Blue 8/11/2016 9:58:01 AM
EXACT Sciences (EXAS) To Participate In Canaccord Genuity 36th Annual Growth Conference 8/8/2016 11:28:05 AM
3 Reasons Little EXACT Sciences (EXAS) is One of the Market's Best Performers 8/2/2016 7:15:27 AM
EXACT Sciences (EXAS) Grants Inducement Restricted Stock Unit Awards To Recently Hired Employees 8/1/2016 10:08:18 AM
EXACT Sciences (EXAS) Announces Upsizing And Pricing Of Public Offering Of Common Stock 7/28/2016 6:35:01 AM
EXACT Sciences (EXAS) Completes 54,000 Cologuard Tests During The Second Quarter 7/26/2016 6:38:43 AM
EXACT Sciences (EXAS) Release: NCQA Proposes Inclusion Of Cologuard In 2017 HEDIS Quality Measures 7/14/2016 7:40:27 AM
EXACT Sciences (EXAS) To Host Second-Quarter 2016 Results, Annual Meeting Webcasts And Calls 6/29/2016 10:56:54 AM
EXACT Sciences (EXAS)' Cologuard Included In Final USPSTF Colorectal Cancer Screening Recommendations 6/16/2016 9:29:37 AM